Volume 3: Issue 4

The scientific program of the Pulmonary Hypertension Association is guided by the association's Scientific Leadership Council. The Council includes the following health care professionals:

Robyn J. Barst, MD, SLC Chair, Columbia Presbyterian Medical Center Babies Hospital, New York, Ny
David B. Badesch, MD, SLC Vice-Chair, Chair, Nominations Committeee, University of Colorado Health Sciences Center, Denver, CO
Raymond L. Benza, MD, University of Alabama, Birmingham, AL
Richard N. Channick, MD, UCSD Medical Center, San Diego, CA
C. Gregory Elliott, MD, LDS Hospital, University of Utah School of Medicine, Salt Lake City, UT
Karen Fagan, MD,

[Editor's note: Editor-in-Chief Victor Tapson, MD, interviewed a select panel of experts in pulmonary hypertension to obtain their review and comments on the new evidence-based clinical practice guidelines of the American College of Chest Physicians. Please see the Editor's Memo for more information.]

The Scientific Leadership Council of the Pulmonary Hypertension Association

Under the Tent of the New ACCP Guidelines in PAH: Room for Debate, Comment, Analysis

From ACCP Guidelines to Pharmacogenomics of PH, Lewis Rubin, MD, Stands Tall as a Prime Mover

Pulmonary Arterial Hypertension: Diagnostic Considerations

Conference Abstracts

Guest Editor’s Memo

A Roundtable Discussion Addressing Patient-Centered Care and Quality of Life in Patients With Pulmonary Arterial Hypertension

Editor’s Memo

Pulmonary Hypertension Associated With Parenchymal Lung Disease